Suppr超能文献

实验性肾性高血压中的血管活性肽

Vasoactive peptides in experimental renal hypertension.

作者信息

Johnston C I, Pullan P T, Walter N M

出版信息

Klin Wochenschr. 1978;56 Suppl 1:81-5. doi: 10.1007/BF01477457.

Abstract
  1. Blood pressure is controlled by both integrated neurogenic and humoral vasoactive mechanisms. 2. Both vasopressor (angiotensin and vasopressin) and vasodepressor (bradykinin) hormonal peptides have been identified. 3. In acute experimental renal hypertension in the rat plasma renin, angiotensin and vasopressin have all been shown to be elevated. 4. Associated with this increase in vasopressor hormonal peptides, urinary kallikrein excretion has been demonstrated to be reduced during the development of renal hypertension. 5. The level of blood pressure achieved in experimental renal hypertension is probably a summation of these vasoactive peptides as well as other factors.
摘要
  1. 血压受神经源性和体液血管活性机制的综合调控。2. 已鉴定出血管升压素(血管紧张素和血管加压素)和血管降压素(缓激肽)等激素肽。3. 在大鼠急性实验性肾性高血压中,血浆肾素、血管紧张素和血管加压素均已显示升高。4. 与血管升压素激素肽的这种增加相关,在肾性高血压发展过程中,尿激肽释放酶排泄已被证明减少。5. 实验性肾性高血压中达到的血压水平可能是这些血管活性肽以及其他因素的总和。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验